摘要
目的探讨体外膈肌起搏器治疗化疗相关性呃逆的临床效果观察。方法选取2018年1—12月我院收治的98例化疗患者为研究对象,随机将其等分为对照组与观察组,对照组实施常规干预,观察组在对照组基础上实施体外膈肌起搏器治疗,比较两组膈肌功能、呃逆症状改善情况。结果观察组最大吸气腹压呼末膈肌厚度、吸气末膈肌厚度、膈肌增厚率均优于对照组(P<0.05);观察组腹胀、食欲减退、泛酸、嗳气、反胃评分均优于对照组(P<0.05)。结论应用体外膈肌起搏器治疗化疗相关性呃逆可有效提高膈肌收缩力,促进膈肌活动恢复正常,从而改善呃逆症状,提高化疗的远期疗效,值得临床推广应用。
Objective To explore the clinical effect observation of the external diaphragm pacemaker for the treatment of chemotherapy-related hiccups.Methods To select 98 cases of patients with chemotherapy admitted to our hospital from January to December 2018 as the study objects,and they were randomly divided into a control group and an observation group.The control group implemented routine intervention.The observation group was treated with an external diaphragm pacemaker on the basis of the control group to compare the improvement of diaphragm function and hiccup symptoms between the two groups.Results The diaphragm thickness when it was end-respiratory and diaphragm thickness when it was end-inspiration with maximum inhaled abdominal pressure,and diaphragm thickening rate in the observation group were better than those in the control group(P<0.05).The bloating,decreased appetite,pantothenic acid,belching,and nausea scores in the observation group were better than those in the control group(P<0.05).Conclusion The application of the external diaphragm pacemaker for the treatment of chemotherapy-related hiccups can effectively improve the contractility of the diaphragm and promote the normalization of diaphragm activity,thereby improving hiccup symptoms and improving the long-term efficacy of chemotherapy.It was worthy of clinical promotion and application.
作者
廖荣荣
王碧
陈晶晶
朱海慧
LIAO Rong-rong;WANG Bi;CHEN Jing-jing;ZHU Hai-hui
出处
《护理实践与研究》
2020年第13期85-87,共3页
Nursing Practice and Research
基金
2018年度省医学科研基金立项项目(A2018465)
关键词
体外膈肌起搏器
化疗相关性呃逆
呼气末膈肌厚度
吸气末膈肌厚度
External diaphragm pacemaker
Chemotherapy-related hiccups
End-respiratory diaphragm thickness
End-inspiration diaphragm thickness
